Mary Stedman, MD, graduated medical school from USF and has been practicing psychiatry in the Tampa since 1992. She is also board certified in her specialty and a Life Fellow of the APA. She offers cutting edge psychiatric assessment and treatment. One focus of her practice is NeuroStar TMS as a treatment for depression in Tampa.
Learn more
Dr. Austin Vangelena graduated from Columbus Central University School of Medicine in Belize where he received his Doctor of Medicine. Prior to pursuing his medical degree, Austin completed his Bachelor of Science studies at the University of Detroit Mercy. Throughout his educational journey, Austin developed a deep understanding...
Learn more
It’s safe and easy to tolerate, and has patented precision technology to ensure you receive the right dose to the right location, every time.
It is the #1 TMS choice of doctors.
NeuroStar is an FDA-cleared device that delivers a therapy called transcranial magnetic stimulation (TMS), which uses a targeted pulsed magnetic field, similar to what is used in a magnetic resonance imaging (MRI) machine. This magnetic field stimulates areas of the brain that are underactive in people with depression. Call today for more information 813-971-8311 and click here to learn more about TMS Therapy.
Because every second counts, and every minute matters.
Every day we make a difference, finding better ways to prevent, detect, diagnose and treat illnesses.
Stedman Clinical Trials offers professional recruitment, trial and administrative services across a variety of indications, with a central focus on psychological disorders and neuro-degenerative diseases such as Alzheimer’s. Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a research study.
MEMORIES ARE WHAT MAKES US HUMAN
We are seeking individuals between the ages of 55-80 who have been diagnosed with Alzheimer’s Disease to participate in a clinical research study.
YOU DON'T HAVE TO LIVE WITH LONELINESS
We are seeking individuals ages 18 and older who have been diagnosed with major depression, and are currently being treated with an antidepressant, to participate in a clinical research study.
